◀ Back to IL3
IL3 — PTPN11
Pathways - manually collected, often from reviews:
-
NCI Pathway Database IL3-mediated signaling events:
IL3/IL3RA/CSF2RB (dodecamer)/JAK2/JAK2/SHP2 complex (CSF2RB-JAK2-PTPN11-IL3-IL3RA)
→
GRB2/GAB2 complex (GRB2-GAB2)
(modification, collaborate)
Edmead et al., Cell Signal 2006, Welham et al., J Biol Chem 1994, Gu et al., J Biol Chem 1997, Craddock et al., J Biol Chem 1997, Gu et al., Mol Cell 1998
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database IL3-mediated signaling events:
IL3/IL3RA/CSF2RB (dodecamer)/JAK2/JAK2/SHP2 complex (CSF2RB-JAK2-PTPN11-IL3-IL3RA)
→
IL3/IL3RA/CSF2RB (dodecamer)/JAK2/JAK2/SHP2/GRB2/GAB2 complex (CSF2RB-JAK2-PTPN11-IL3-IL3RA-GRB2-GAB2)
(modification, collaborate)
Edmead et al., Cell Signal 2006, Welham et al., J Biol Chem 1994, Gu et al., J Biol Chem 1997, Craddock et al., J Biol Chem 1997, Gu et al., Mol Cell 1998
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database IL3-mediated signaling events:
GRB2/GAB2 complex (GRB2-GAB2)
→
IL3/IL3RA/CSF2RB (dodecamer)/JAK2/JAK2/SHP2/GRB2/GAB2 complex (CSF2RB-JAK2-PTPN11-IL3-IL3RA-GRB2-GAB2)
(modification, collaborate)
Edmead et al., Cell Signal 2006, Welham et al., J Biol Chem 1994, Gu et al., J Biol Chem 1997, Craddock et al., J Biol Chem 1997, Gu et al., Mol Cell 1998
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database IL3-mediated signaling events:
IL3/IL3RA/CSF2RB (dodecamer)/JAK2/JAK2/SHP2 complex (CSF2RB-JAK2-PTPN11-IL3-IL3RA)
→
IL3/IL3RA/CSF2RB (dodecamer)/JAK2/JAK2 complex (CSF2RB-JAK2-IL3-IL3RA)
(modification, collaborate)
Welham et al., J Biol Chem 1994, Bone et al., J Biol Chem 1997
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL3-mediated signaling events:
IL3/IL3RA/CSF2RB (dodecamer)/JAK2/JAK2/SHP2 complex (CSF2RB-JAK2-PTPN11-IL3-IL3RA)
→
SHP2 (PTPN11)
(modification, collaborate)
Welham et al., J Biol Chem 1994, Bone et al., J Biol Chem 1997
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL3-mediated signaling events:
IL3/IL3RA/CSF2RB (dodecamer)/JAK2/JAK2 complex (CSF2RB-JAK2-IL3-IL3RA)
→
SHP2 (PTPN11)
(modification, collaborate)
Welham et al., J Biol Chem 1994, Bone et al., J Biol Chem 1997
Evidence: mutant phenotype, assay, physical interaction
-
Reactome Reaction:
IL3
→
PTPN11
(reaction)
Bone et al., J Biol Chem 1997
-
Reactome Reaction:
IL3
→
PTPN11
(indirect_complex)
Bone et al., J Biol Chem 1997
Text-mined interactions from Literome
Wheadon et al., Biochem J 2003
:
To investigate the
role of
SHP-2 in
IL-3 signalling in greater detail, we have inducibly expressed WT ( wild-type ) or two potentially substrate trapping mutant forms of SHP-2, generated by mutation of Asp-425 to Ala ( D425A ) or Cyst-459 to Ser ( C459S ), in IL-3 dependent BaF/3 cells
Welham et al., J Biol Chem 1994
:
Interleukin (IL)-3 and granulocyte/macrophage colony stimulating factor, but not IL-4,
induce tyrosine phosphorylation, activation, and association of
SHPTP2 with Grb2 and phosphatidylinositol 3'-kinase
Chin et al., Biochem Biophys Res Commun 1997
:
Erythropoietin and
IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc,
SHP-2 , and Cbl in hematopoietic cells ... The present study demonstrates that erythropoietin (Epo) and
IL-3 induce tyrosine phosphorylation of the SH2/SH3 containing adapter protein CrkL and its transient association with tyrosine phosphorylated
SHP-2 , Shc, and Cbl in a murine IL-3 dependent cell line, 32D, expressing the Epo receptor (EpoR)